THINK THERAPEUTICS, INC.
Newton, MA · Biotech · Private
Tolerization vaccines for autoimmune diseases designed using a novel immunogenicity assay and machine learning-optimized multi-epitope selection
thinktx.co →- Grants
- $1.0M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 15 granted · 25 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Machine learning optimized autoimmune therapeutics with a focus on Type 1 Diabetes | $306,500 | |
| Federal grant | Department of Health and Human Services · Phase I · Machine learning optimized autoimmune therapeutics with a focus on Type 1 Diabetes | $306,500 | |
| Federal grant | Department of Health and Human Services · Phase I · Brilliant epitopes for improved cancer vaccines | $405,599 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2679 | Extended Longevity, Inc. | — | $10K |
| 2680 | EIGER GROUP INTERNATIONAL, INC. | — | — |
| 2681 | MOLECULAR WORLD HEALTH, INC. | — | $5K |
| 2682 | THINK THERAPEUTICS, INC. | — | — |
| 2683 | Integrated Biotherapeutic Vaccines, Inc. | — | $3K |
| 2684 | Ironfist Therapeutics, Inc. | — | $2K |
| 2685 | Eyebiotech Ltd | — | $486 |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods For Discovering And Using Lymphocytes With Antigen Specificitygranted
- Compositions And Methods For Optimized Covid Peptide Vaccinesapplication
- Computational Generation Of Artificial Proteins With Programmable Immunogenicityapplication
- Immunogenic Compositions Comprising Nucleic Acids For Ras Peptidesapplication
- Multiplexed Testing Of Lymphocytes For Antigen Specificitygranted
- Compositions For Optimized Influenza Peptide Vaccinesapplication
- Compositions And Methods For Optimized Hiv Peptide Vaccinesapplication
- Immunogenic Compositions Comprising Nucleic Acids For Ras Peptides And Their Use For Treating Cancergranted
- Compositions For Optimized Bcr-abl Peptide Vaccinesapplication
- Compositions And Method For Optimized Peptide Vaccines Using Residue Optimizationapplication
- Compositions For Optimized Bcr-abl Peptide Vaccinesgranted
- Method Of Compact Peptide Vaccines Using Residue Optimizationapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.